Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 5
2003 5
2004 5
2005 5
2006 3
2007 7
2008 5
2009 9
2010 16
2011 18
2012 23
2013 23
2014 13
2015 28
2016 11
2017 16
2018 24
2019 16
2020 21
2021 47
2022 53
2023 51
2024 17

Text availability

Article attribute

Article type

Publication date

Search Results

346 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and Safety of Etrasimod in Patients with Moderately to Severely Active Isolated Proctitis: Results From the Phase 3 ELEVATE UC Clinical Programme.
Peyrin-Biroulet L, Dubinsky MC, Sands BE, Panés J, Schreiber S, Reinisch W, Feagan BG, Danese S, Yarur AJ, D'Haens GR, Goetsch M, Wosik K, Keating M, Lazin K, Wu J, Modesto I, McDonnell A, Bartolome L, Vermeire S. Peyrin-Biroulet L, et al. Among authors: reinisch w. J Crohns Colitis. 2024 Apr 13:jjae038. doi: 10.1093/ecco-jcc/jjae038. Online ahead of print. J Crohns Colitis. 2024. PMID: 38613425
Comparative efficacy and safety of subcutaneous infliximab and vedolizumab in patients with Crohn's disease and ulcerative colitis included in randomised controlled trials.
Peyrin-Biroulet L, Arkkila P, Armuzzi A, Danese S, Ferrante M, Jordi Guardiola, Jahnsen J, Louis E, Lukáš M, Reinisch W, Roblin X, Smith PJ, Kwon T, Kim J, Yoon S, Kim DH, Atreya R. Peyrin-Biroulet L, et al. Among authors: reinisch w. BMC Gastroenterol. 2024 Mar 27;24(1):121. doi: 10.1186/s12876-024-03163-5. BMC Gastroenterol. 2024. PMID: 38539103 Free PMC article.
Defining Endoscopic Remission in Crohn's Disease: MM-SES-CD and SES-CD Thresholds Associated With Low Risk of Disease Progression.
Narula N, Wong ECL, Dulai PS, Patel J, Marshall JK, Yzet C, Jairath V, Ungaro R, Colombel JF, Reinisch W; CALM LTE investigators. Narula N, et al. Among authors: reinisch w. Clin Gastroenterol Hepatol. 2024 Feb 28:S1542-3565(24)00212-X. doi: 10.1016/j.cgh.2024.02.009. Online ahead of print. Clin Gastroenterol Hepatol. 2024. PMID: 38428709 Free article.
Switching from intravenous to subcutaneous infliximab maintenance therapy in inflammatory bowel disease: Post hoc longitudinal analysis of a randomized trial.
Schreiber S, D'Haens G, Cummings F, Irving PM, Ye BD, Ben-Horin S, Kim DH, Jeong AL, Reinisch W. Schreiber S, et al. Among authors: reinisch w. Dig Liver Dis. 2024 Feb 15:S1590-8658(23)01121-0. doi: 10.1016/j.dld.2023.12.013. Online ahead of print. Dig Liver Dis. 2024. PMID: 38365502 Free article.
Outcomes and endpoints of postoperative recurrence in Crohn's Disease: systematic review and consensus conference.
Hammoudi N, Sachar D, D'Haens G, Reinisch W, Kotze PG, Vermeire S, Schölmerich J, Kamm MA, Griffiths A, Panes J, Ghosh S, Siegel CA, Bemelman W, O'Morain C, Steinwurz F, Fleshner P, Mantzaris GJ, Sands B, Abreu MT, Dotan I, Turner D, Dignass A, Allez M; International Organization for the Study of Inflammatory Bowel Diseases (IOIBD).. Hammoudi N, et al. Among authors: reinisch w. J Crohns Colitis. 2023 Dec 19:jjad205. doi: 10.1093/ecco-jcc/jjad205. Online ahead of print. J Crohns Colitis. 2023. PMID: 38112601
346 results